FDA Adverse Event Malfunction Summary report: N

TRIMA ACCEL

MDR report key: 4791742 · Received May 22, 2015

Report

Report Number
1722028-2015-00187
Event Type
Malfunction
Date Received
May 22, 2015
Date of Event
April 21, 2015
Report Date
April 28, 2015
Manufacturer
TERUMO BCT
Product Code
GKT
PMA / PMN Number
BK140180
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL EVALUATION METHOD CODE: STERILIZATION PROCESS REVIEW INVESTIGATION: A TRIMA SET WAS RETURNED FOR INVESTIGATION. VISUAL INSPECTION CONFIRMED THE SET WAS ASSEMBLED CORRECTLY WITH NO KINKS, OCCLUSIONS OR MISSING CLAMPS. FLOW OF SOLUTION WAS OBSERVED THROUGH THE LRS CHAMBER. THERE WERE NO SIGNS OF DAMAGE TO THE CHANNEL AND THERE WERE NO WITNESS MARKS ON THE LOOP ASSEMBLY WHICH SUGGESTED THE SET WAS LOADED CORRECTLY. THE DEVICE HISTORY RECORDS (DHR) WERE REVIEWED FOR THIS LOT. THERE WERE NO EVENTS NOTED IN THE DHR THAT WOULD HAVE CONTRIBUTED TO THE ELEVATED WBC COUNT EXPERIENCED BY THE CUSTOMER. ROOT CAUSE: THE INVESTIGATION OF THE RETURNED SET DID NOT LEAD TO A CONCLUSIVE ROOT CAUSE. A DEFINITIVE ROOT CAUSE FOR THE OBSERVED LEUKOREDUCTION FAILURE REMAINS UNDETERMINED AT THIS TIME. POSSIBLE ROOT CAUSES WERE PROVIDED IN THE INITIAL REPORT FOR THIS EVENT.

Additional Manufacturer Narrative · 1

INVESTIGATION: THE RUN DATA FILE (RDF) WAS ANALYZED FOR THIS EVENT. REVIEW OF THE RUN DATA FILE DID NOT SHOW A DEFINITIVE ROOT CAUSE FOR THE HIGHER THAN EXPECTED WBC COUNT OF THE PLATELET PRODUCT. SIGNALS SHOWED THAT PLATELETS EXITED THE CHAMBER 6 MINUTES AFTER THE VALVE WAS OPENED AND THE CONCENTRATION WAS CONSISTENT DURING THE COLLECTION. IT IS POSSIBLE THAT AN ESCAPE OF WBCS FROM THE LRS CHAMBER DURING THE COLLECTION CONTRIBUTED TO THE HIGHER THAN EXPECTED WBC CONTENT IN THE PLATELET PRODUCT. BASED ON THE AVAILABLE INFORMATION, IT IS ALSO POSSIBLE THAT THIS LEUKO REDUCTION FAILURE MAY BE DONOR RELATED. INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE PROVIDED.

Description of Event or Problem · 1

THE CUSTOMER WOULD LIKE THE RUN DATA FILE INVESTIGATED TO DETERMINE A POSSIBLE CAUSE FOR THE ELEVATED WHITE BLOOD CELL (WBC) CONTENT IN THE PLATELET PRODUCT. THERE WAS NOT A TRANSFUSION RECIPIENT OR PATIENT INVOLVED AT THE TIME OF THE RESIDUAL WHITE BLOOD CELL (RWBC) TESTING, THEREFORE NO PATIENT INFORMATION IS REASONABLY KNOWN AT THE TIME OF THE EVENT. TERUMO BCT IS AWAITING RETURN OF THE DISPOSABLE SET FOR EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
335557 TRIMA ACCEL TRIMA ACCEL PLATELET + SAMPLER, AUTOPAS, MLT PLS SET GKT TERUMO BCT 12W1207

Patients

Seq Age Sex Outcome Treatment
1 Other